Evidence map›Paper›PMID 40426516›Full record

ArticleAntibiotics (Basel, Switzerland)2025

Genetic Variation in the

Mia Aarris, Frederik Boëtius Hertz, Karen Leth Nielsen, Alexander Sato, Helle Krogh Johansen, Henrik Westh, Michael Kemp, Svend Ellermann-Eriksen, Anders Løbner-Olesen, Niels Frimodt-Møller and 1 more

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mia AarrisDepartment of Clinical Microbiology, Rigshospitalet, 2100 Copenhagen, Denmark.
Frederik Boëtius HertzDepartment of Clinical Microbiology, Rigshospitalet, 2100 Copenhagen, Denmark.ORCID 0000-0003-0888-4616
Karen Leth NielsenDepartment of Clinical Microbiology, Rigshospitalet, 2100 Copenhagen, Denmark.ORCID 0000-0002-7912-1985
Alexander SatoInstitute of Biology, University of Copenhagen, 2200 Copenhagen, Denmark.
Helle Krogh JohansenDepartment of Clinical Microbiology, Rigshospitalet, 2100 Copenhagen, Denmark.ORCID 0000-0003-0268-3717
Henrik WesthDepartment of Clinical Microbiology, Hvidovre Hospital, 2650 Hvidovre, Denmark.
Michael KempDepartment of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, 2100 Copenhagen, Denmark.ORCID 0000-0001-5989-0421
Svend Ellermann-EriksenDepartment of Clinical Microbiology, Aarhus University Hospital, 8200 Aarhus, Denmark.ORCID 0000-0001-9324-911X
Anders Løbner-OlesenInstitute of Biology, University of Copenhagen, 2200 Copenhagen, Denmark.ORCID 0000-0002-0344-6417
Niels Frimodt-MøllerDepartment of Clinical Microbiology, Rigshospitalet, 2100 Copenhagen, Denmark.ORCID 0000-0003-1966-8302
Godefroid CharbonInstitute of Biology, University of Copenhagen, 2200 Copenhagen, Denmark.ORCID 0000-0003-4792-1889

Funding

CSRD VA 1Lundbeck Foundation R436-2023-1224Novo Nordisk Foundation NNF18SA0035306Novo Nordisk Foundation NNF19OC005641
6 · The paper itself

Abstract

BACKGROUND/

objectives

methodsA collection of 489

resultsFrom this collection, 71% of isolates were methicillin-susceptible

conclusionsOur findings demonstrate that the new F variant of BlaZ is sufficient to render

Indexed as

BlaZborderline oxacillin-resistant (BORSA)methicillin-susceptible S. aureus (MSSA)oxacillin

Identifiers

PMID40426516
PMCPMC12108325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.